January In January 2016, the Rongxiang Xu, MD, Center for Regenerative Therapeutics at BIDMC of Harvard Medical School and Rongxiang Xu Center of Regenerative Life Science at USC Davis School of Gerontology were established, which are the research and technological support centers for the global development of regenerative life science and regenerative medical technology.
May In May 2016, The first batch of Chinese regenerative medical experts visited the “Rongxiang Xu, MD, Center for Regenerative Therapeutics” at BIDMC of Harvard Medical School.
July In July 2016, Beijing Rongxiang Regenerative Medicine Research Laboratory became the member of the United Nations Academic Impact (UNAI).
November In November 2016,Rongxiang Xu MD Professorship in Surgery in the Field of Regenerative Therapeutics
May In May 2015, Kevin Xu assumed the Board Chairman of MEBO International and MEBO International stepped into a new era of international development.
September In September 2015, the Clinton Global Initiative (CGI) Commitment“From Urban to Rural: Training Doctors on Moist Exposed Burn Therapy（MEBT）”was launched, which aimed to train 20,000 doctors in China on the application of regenerative medical technology.
In 2001, the “roadmap of human tissue organ in situ replication engineering” was declared, which laid the theoretical and clinical application foundation for utilizing the cells in situ and in vivo to treat diseases.
In 2001, the achievement of in situ and in vitro regeneration and cloning of gastrointestinal organs was released, which is another success in the field of tissue organ regenerative restoration, following the skin in situ regenerative restoration by culturing stem cells in situ.
